GGM Financials LLC Invests $7.34 Million in Astera Labs, Inc. $ALAB

GGM Financials LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 81,165 shares of the company’s stock, valued at approximately $7,339,000. Astera Labs comprises approximately 1.4% of GGM Financials LLC’s investment portfolio, making the stock its 19th largest position.

Several other institutional investors have also modified their holdings of ALAB. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs during the 2nd quarter worth $29,000. Bernard Wealth Management Corp. purchased a new stake in shares of Astera Labs during the 2nd quarter worth $36,000. GAMMA Investing LLC lifted its position in shares of Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after purchasing an additional 284 shares during the last quarter. Harbour Investments Inc. lifted its position in shares of Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after purchasing an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. purchased a new stake in shares of Astera Labs during the 1st quarter worth $48,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

NASDAQ ALAB opened at $170.28 on Tuesday. The firm has a market cap of $28.30 billion, a PE ratio of 304.07, a P/E/G ratio of 4.11 and a beta of 1.43. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The firm’s fifty day moving average is $196.47 and its two-hundred day moving average is $133.16.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs’s quarterly revenue was up 149.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Cowen began coverage on shares of Astera Labs in a research report on Tuesday, September 30th. They set a “hold” rating for the company. Needham & Company LLC lifted their price target on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Sunday. Finally, Citigroup lifted their price target on shares of Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $162.06.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 25,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $173.42, for a total value of $4,335,500.00. Following the transaction, the director directly owned 99,154 shares in the company, valued at approximately $17,195,286.68. The trade was a 20.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director owned 385,863 shares in the company, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,092,997 shares of company stock valued at $192,231,120 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.